1. 1464PKEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?. (23rd October 2018) Authors: Rodriguez Abreu, D; Garassino, M C; Esteban, E; Speranza, G; Felip, E; Domine, M; Hochmair, M J; Powell, S F; Cheng, S Y-S; Bischoff, H; Peled, N; Hui, R; Reck, M; Garon, E B; Boyer, M; Grossi, F; Jennens, R; Yang, J; Pietanza, M C; Gadgeel, S M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An analysis based on sex&gender in the chest pain unit of an emergency department during the last 12 years. (26th April 2021) Authors: Martinez-Nadal, G; Miro, O; Matas, A; Cepas, P; Aldea, A; Izquierdo, M; Coll-Vinent, B; Garcia, A; Carbo, M; Manuel, O; Aguilo, S; Esteban, E; Lopez-Barbeito, B Journal: European heart journal Issue: Volume 10(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LBA5 KRAS mutational status and efficacy in KEYNOTE-189: Pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo plus chemo as first-line therapy for metastatic non-squamous NSCLC. (15th December 2019) Authors: Gadgeel, S; Rodriguez-Abreu, D; Felip, E; Esteban, E; Speranza, G; Reck, M; Hui, R; Boyer, M; Garon, E B; Horinouchi, H; Cristescu, R; Aurora-Garg, D; Lunceford, J; Kobie, J; Ayers, M; Piperdi, B; Pietanza, M C; Garassino, M C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗